X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (5006) 5006
Publication (794) 794
Book Review (80) 80
Book Chapter (64) 64
Dissertation (19) 19
Conference Proceeding (8) 8
Book / eBook (4) 4
Magazine Article (2) 2
Newsletter (2) 2
Data Set (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (3158) 3158
index medicus (2511) 2511
microsatellite instability (2039) 2039
mismatch repair (1993) 1993
oncology (1690) 1690
mutation (1603) 1603
dna mismatch repair (1481) 1481
cancer (1428) 1428
female (1351) 1351
dna repair (1346) 1346
colorectal cancer (1194) 1194
male (1117) 1117
genetics & heredity (1014) 1014
animals (983) 983
genetic aspects (981) 981
tumors (974) 974
middle aged (931) 931
dna (763) 763
adult (754) 754
aged (747) 747
colorectal neoplasms - genetics (698) 698
mutl protein homolog 1 (684) 684
research (681) 681
immunohistochemistry (678) 678
colorectal neoplasms, hereditary nonpolyposis - genetics (660) 660
biochemistry & molecular biology (638) 638
colon-cancer (623) 623
nonpolyposis colorectal-cancer (604) 604
mice (601) 601
analysis (584) 584
lynch syndrome (567) 567
mutations (567) 567
colorectal-cancer (560) 560
proteins (557) 557
genes (554) 554
deoxyribonucleic acid--dna (552) 552
dna damage (530) 530
dna-binding proteins - genetics (529) 529
cell biology (492) 492
base pair mismatch (491) 491
digestive system diseases (490) 490
pathology (490) 490
mismatch repair deficiency (472) 472
article (457) 457
dna methylation (436) 436
expression (421) 421
chemotherapy (403) 403
gene mutations (396) 396
dna mismatch repair - genetics (389) 389
phenotype (389) 389
prognosis (388) 388
dna repair - genetics (386) 386
lynch-syndrome (381) 381
nuclear proteins - genetics (378) 378
aged, 80 and over (374) 374
genetics (368) 368
muts homolog 2 protein - genetics (354) 354
adaptor proteins, signal transducing (340) 340
congenital, hereditary, and neonatal diseases and abnormalities (339) 339
gene expression (335) 335
gene (334) 334
genetic predisposition to disease (322) 322
health aspects (322) 322
colorectal neoplasms - pathology (320) 320
apoptosis (312) 312
toxicology (310) 310
carcinoma (308) 308
multidisciplinary sciences (307) 307
methylation (305) 305
base sequence (304) 304
msh2 (304) 304
colorectal carcinoma (287) 287
mlh1 (285) 285
saccharomyces-cerevisiae (285) 285
endometrial cancer (284) 284
microsatellite repeats (283) 283
genomic instability (282) 282
adaptor proteins, signal transducing - genetics (281) 281
neoplasms (281) 281
risk (280) 280
immunotherapy (279) 279
research article (279) 279
genetic research (278) 278
care and treatment (277) 277
muts homolog 2 protein (277) 277
neoplasm proteins - genetics (276) 276
gastroenterology & hepatology (273) 273
hmlh1 (270) 270
risk factors (267) 267
carrier proteins (266) 266
genomes (264) 264
polymerase chain reaction (263) 263
mismatch-repair (262) 262
nuclear proteins (261) 261
genomics (260) 260
dna-binding proteins - metabolism (259) 259
proto-oncogene proteins - genetics (259) 259
germ-line mutation (257) 257
escherichia-coli (251) 251
hnpcc (249) 249
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (5000) 5000
French (20) 20
German (19) 19
Chinese (7) 7
Russian (5) 5
Japanese (4) 4
Korean (3) 3
Spanish (3) 3
Bulgarian (2) 2
Hungarian (1) 1
Norwegian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The New England Journal of Medicine, ISSN 0028-4793, 06/2015, Volume 372, Issue 26, pp. 2509 - 2520
Persons with mismatch repair–deficient tumors are more likely than persons with mismatch repair–proficient tumors to benefit from pembrolizumab — which... 
MEDICINE, GENERAL & INTERNAL | COLORECTAL CARCINOMAS | ANTI-PD-L1 ANTIBODY | SAFETY | MICROSATELLITE INSTABILITY | DNA | GERMLINE MUTATIONS | PREDISPOSE | CLINICAL ACTIVITY | CANCER | LYMPHOCYTES | Antibodies, Monoclonal, Humanized - adverse effects | Antibodies, Monoclonal, Humanized - therapeutic use | Colorectal Neoplasms - genetics | Humans | Middle Aged | Kaplan-Meier Estimate | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Antineoplastic Agents - therapeutic use | Adenocarcinoma - drug therapy | Adenocarcinoma - secondary | Disease-Free Survival | Neoplasm Metastasis - genetics | Neoplasm Metastasis - drug therapy | Antineoplastic Agents - adverse effects | Colorectal Neoplasms - drug therapy | DNA Mismatch Repair | Adult | Female | Adenocarcinoma - genetics | Aged | Colorectal Neoplasms - pathology | Antibody diversity | Carcinoma | Genetic disorders | Analysis | Research | Risk factors | Cancer | Tumors | Antigens | Yeast | PD-1 protein | Colorectal carcinoma | Body weight | Colorectal cancer | Autoantigens | DNA repair | Survival | Metastases | Pembrolizumab | Immune checkpoint | Immunogenicity | Mismatch repair | Death | Mutation | Genetic recombination | Cancer therapies | Drug dosages | Immune system | Medical research | Melanoma | Patients | Studies | Hypotheses | Pancreatic cancer | Epigenetics | Biomarkers | Ligands
Journal Article
Science, ISSN 0036-8075, 07/2017, Volume 357, Issue 6349, pp. 409 - 413
The genomes of cancers deficient in mismatch repair contain exceptionally high numbers of somatic mutations. In a proof-of-concept study, we previously showed... 
CELL LUNG-CANCER | SURVIVAL | COLORECTAL CARCINOMAS | RECEIVING NIVOLUMAB | IMMUNOTHERAPY | MICROSATELLITE INSTABILITY | MULTIDISCIPLINARY SCIENCES | LONG-TERM SAFETY | NEOANTIGENS | CHECKPOINT BLOCKADE | LYMPHOCYTES | Neoplastic Syndromes, Hereditary - immunology | Colorectal Neoplasms - genetics | Humans | Middle Aged | Male | Programmed Cell Death 1 Receptor - antagonists & inhibitors | Neoplastic Syndromes, Hereditary - mortality | Young Adult | Colorectal Neoplasms - therapy | Brain Neoplasms - immunology | DNA Mismatch Repair | Aged, 80 and over | Adult | Female | Neoplastic Syndromes, Hereditary - genetics | Brain Neoplasms - mortality | Biomarkers, Tumor - antagonists & inhibitors | Colorectal Neoplasms - mortality | Antibodies, Monoclonal, Humanized - therapeutic use | Antigens, Neoplasm - immunology | Brain Neoplasms - genetics | Disease-Free Survival | Colorectal Neoplasms - immunology | Cell Cycle Checkpoints - drug effects | Brain Neoplasms - therapy | Neoplastic Syndromes, Hereditary - therapy | T-Lymphocytes - immunology | Aged | Mutation | Programmed Cell Death 1 Receptor - immunology | Colorectal cancer | Genetic aspects | Nucleotide sequencing | Health aspects | DNA repair | Methods | Tumors | DNA sequencing | Yeast | PD-1 protein | Antibodies | Clinical trials | Genomes | Functional analysis | Lymphocytes T | Patients | Survival | Colon cancer | Immune checkpoint | Immunotherapy | Mismatch repair | Pancreatic cancer | Biomarkers | Colon | Solid tumors | Genetic recombination | Repair | Cancer | Apoptosis
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 11/2015, Volume 373, Issue 20, pp. 1979 - 1979
Journal Article
MODERN PATHOLOGY, ISSN 0893-3952, 07/2019, Volume 32, Issue 7, pp. 977 - 987
Journal Article
Gastroenterology, ISSN 0016-5085, 2014, Volume 147, Issue 6, pp. 1308 - 1316.e1
Journal Article
European Journal of Cancer, ISSN 0959-8049, 2013, Volume 50, Issue 5, pp. 987 - 996
Journal Article